Trabectedin vs Best Supportive Care in Patients With Pretreated Soft Tissue Sarcoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Annals of Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A Randomized Phase III Trial Comparing Trabectedin to Best Supportive Care in Patients With Pre-Treated Soft Tissue Sarcoma: T-SAR, a French Sarcoma Group Trial
Ann. Oncol 2021 Apr 28;[EPub Ahead of Print], A Le Cesne, JY Blay, D Cupissol, A Italiano, C Delcambre, N Penel, N Isambert, C Chevreau, E Bompas, F Bertucci, L Chaigneau, S Piperno-Neumann, S Salas, M Rios, C Guillemet, JO Bay, I Ray-Coquard, L Haddag, J Bonastre, R Kapso, A Fraslin, N Bouvet, O Mir, S FoulonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.